| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |